[go: up one dir, main page]

FR2917173B1 - Procede multiplexe de detection d'une infection - Google Patents

Procede multiplexe de detection d'une infection

Info

Publication number
FR2917173B1
FR2917173B1 FR0755626A FR0755626A FR2917173B1 FR 2917173 B1 FR2917173 B1 FR 2917173B1 FR 0755626 A FR0755626 A FR 0755626A FR 0755626 A FR0755626 A FR 0755626A FR 2917173 B1 FR2917173 B1 FR 2917173B1
Authority
FR
France
Prior art keywords
multiplex method
detecting infection
infection
detecting
multiplex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0755626A
Other languages
English (en)
Other versions
FR2917173A1 (fr
Inventor
Christine Charpentier
Stephane Gadelle
Nadine Lambert
Amparo Sanjuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Europe GmbH
Original Assignee
Bio Rad Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0755626A priority Critical patent/FR2917173B1/fr
Application filed by Bio Rad Pasteur SA filed Critical Bio Rad Pasteur SA
Priority to CN200880019283.7A priority patent/CN101711361B/zh
Priority to CA2687827A priority patent/CA2687827C/fr
Priority to JP2010510823A priority patent/JP5216852B2/ja
Priority to EA200971123A priority patent/EA017206B1/ru
Priority to PCT/EP2008/057111 priority patent/WO2008148883A1/fr
Priority to BRPI0812771A priority patent/BRPI0812771B8/pt
Priority to EP08760681.0A priority patent/EP2160605B1/fr
Priority to US12/600,297 priority patent/US20100151445A1/en
Publication of FR2917173A1 publication Critical patent/FR2917173A1/fr
Application granted granted Critical
Publication of FR2917173B1 publication Critical patent/FR2917173B1/fr
Priority to US13/892,521 priority patent/US9523685B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/02—Hepadnaviridae, e.g. hepatitis B virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • G01N2333/10—Hepatitis A virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR0755626A 2007-06-08 2007-06-08 Procede multiplexe de detection d'une infection Active FR2917173B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR0755626A FR2917173B1 (fr) 2007-06-08 2007-06-08 Procede multiplexe de detection d'une infection
US12/600,297 US20100151445A1 (en) 2007-06-08 2008-06-06 Multiplex Method for Detecting an Infection
JP2010510823A JP5216852B2 (ja) 2007-06-08 2008-06-06 感染を検出するためのマルチプレックス方法
EA200971123A EA017206B1 (ru) 2007-06-08 2008-06-06 Мультиплексный способ выявления инфекции
PCT/EP2008/057111 WO2008148883A1 (fr) 2007-06-08 2008-06-06 Méthode multiplex de détection d'une infection
BRPI0812771A BRPI0812771B8 (pt) 2007-06-08 2008-06-06 método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo
CN200880019283.7A CN101711361B (zh) 2007-06-08 2008-06-06 检测感染的多元方法
CA2687827A CA2687827C (fr) 2007-06-08 2008-06-06 Methode multiplex de detection d'une infection
EP08760681.0A EP2160605B1 (fr) 2007-06-08 2008-06-06 Méthode multiplex de détection d'une infection
US13/892,521 US9523685B2 (en) 2007-06-08 2013-05-13 Multiplex method for detecting an infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0755626A FR2917173B1 (fr) 2007-06-08 2007-06-08 Procede multiplexe de detection d'une infection

Publications (2)

Publication Number Publication Date
FR2917173A1 FR2917173A1 (fr) 2008-12-12
FR2917173B1 true FR2917173B1 (fr) 2009-07-31

Family

ID=38457970

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0755626A Active FR2917173B1 (fr) 2007-06-08 2007-06-08 Procede multiplexe de detection d'une infection

Country Status (9)

Country Link
US (2) US20100151445A1 (fr)
EP (1) EP2160605B1 (fr)
JP (1) JP5216852B2 (fr)
CN (1) CN101711361B (fr)
BR (1) BRPI0812771B8 (fr)
CA (1) CA2687827C (fr)
EA (1) EA017206B1 (fr)
FR (1) FR2917173B1 (fr)
WO (1) WO2008148883A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012103337A2 (fr) 2011-01-26 2012-08-02 The Brigham And Women's Hospital, Inc. Dosages et procédé de séquençage de microbes directement à partir de complexes immuns
US10732178B2 (en) * 2013-01-29 2020-08-04 Bio-Rad Haifa Ltd. Detection assays employing magnetic nanoparticles
CN109828110A (zh) * 2013-04-26 2019-05-31 生物辐射实验室股份有限公司 多重乙肝试验
CN104714028B (zh) * 2015-03-02 2017-01-25 深圳市凯瑞德生物技术有限公司 一种检测IgM抗体的免疫检测方法
WO2016144962A1 (fr) * 2015-03-10 2016-09-15 Bio-Rad Laboratories, Inc. Test de la syphilis combiné tréponémique et non tréponémique
WO2017062535A2 (fr) 2015-10-06 2017-04-13 Bio-Rad Laboratories, Inc. Dosages immunologiques de borrelia et matériaux associés
EP3374769B1 (fr) 2015-11-09 2022-10-26 Bio-Rad Laboratories, Inc. Dosages faisant intervenir de l'avidine et de la biotine
CN109642899B (zh) * 2016-08-31 2024-03-08 荣研化学株式会社 使用由不同的方式固定化抗原的抗原负载不溶性载体粒子的抗体测定法、抗体测定用试剂
ES2929392T3 (es) * 2017-03-01 2022-11-28 Hoffmann La Roche Sistemas, procedimiento y medio legible por ordenador para clasificar una muestra biológica con respecto a la presencia de un analito
JP2021533384A (ja) * 2018-07-27 2021-12-02 ヴェラヴァス インコーポレイテッド バイオマーカーを検出する方法
EP4016080A4 (fr) * 2019-08-16 2023-01-11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Nouveau mode de dosage immunologique dans son ensemble pour déterminer un anticorps total
WO2021203044A2 (fr) * 2020-04-03 2021-10-07 Icahn School Of Medicine At Mount Sinai Dosage à haut rendement pour la circulation d'anticorps contre le coronavirus 2 du syndrome respiratoire aigu sévère
CN115397465A (zh) * 2020-04-24 2022-11-25 美国西门子医学诊断股份有限公司 用于针对抗体的免疫测定的校准和质量控制试剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172561A (fr) 1981-01-28 1984-08-14 Richard H. Decker Methode de detection d'immunoglobulines
EP0189389B1 (fr) * 1985-01-24 1989-04-05 Institut International De Pathologie Cellulaire Et Moleculaire Procédé de dosage immunologique d'anticorps de diverses classes dans un échantillon liquide
JPS6270764A (ja) * 1985-03-08 1987-04-01 Sanko Junyaku Kk 血清中の免疫抗体測定方法
JPS6488369A (en) * 1987-08-14 1989-04-03 Ortho Diagnostic Systems Inc Method of detecting and verifying presence of antibody
JPH05133952A (ja) * 1991-04-03 1993-05-28 Syntex Usa Inc イムノグロブリン類のイムノアツセイ
CA2064972A1 (fr) * 1991-04-03 1992-10-04 John Joseph Rejman Essai immunologique pour immunoglobulines
EP1248110A3 (fr) * 1997-11-18 2005-01-26 Bio-Rad Laboratories, Inc. Dosages immunologiques multiplex de flux, dans lesquels des particules magnétiques font office de phase solide
ITTO980473A1 (it) * 1998-06-02 1999-12-02 Sorin Diagnostics S R L Nuovo procedimento per la rivelazione di anticorpi e/o isotipi di anticorpi specifici per almeno due differenti fasi di un'infezione
WO2001073443A2 (fr) * 2000-03-28 2001-10-04 The Government Of The United State Of America, As Represented By The Secretary Of The Department Of Health And Human Services Procedes et compositions de detection simultanee de plusieurs analytes
JP2002310875A (ja) * 2001-04-16 2002-10-23 National Institute Of Advanced Industrial & Technology 梅毒検査試薬及び梅毒検査方法
EP1501945A4 (fr) * 2002-04-30 2008-02-20 Merck & Co Inc Test multiplexe de papillomavirus humain (hpv)
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
CN1164948C (zh) * 2002-06-06 2004-09-01 成都夸常科技有限公司 一种基于抗原抗体反应的试剂盒
US20070298432A1 (en) * 2003-11-07 2007-12-27 Hep-Genics Pty Ltd Binding Assay Components

Also Published As

Publication number Publication date
WO2008148883A1 (fr) 2008-12-11
EA200971123A1 (ru) 2010-06-30
CN101711361A (zh) 2010-05-19
BRPI0812771B8 (pt) 2021-07-27
BRPI0812771B1 (pt) 2019-01-22
US9523685B2 (en) 2016-12-20
BRPI0812771A2 (pt) 2014-12-02
EP2160605B1 (fr) 2017-11-01
JP2010529443A (ja) 2010-08-26
US20130273525A1 (en) 2013-10-17
CA2687827C (fr) 2017-08-29
US20100151445A1 (en) 2010-06-17
CA2687827A1 (fr) 2008-12-11
CN101711361B (zh) 2016-08-31
EA017206B1 (ru) 2012-10-30
JP5216852B2 (ja) 2013-06-19
EP2160605A1 (fr) 2010-03-10
FR2917173A1 (fr) 2008-12-12

Similar Documents

Publication Publication Date Title
FR2917173B1 (fr) Procede multiplexe de detection d'une infection
FR2913501B1 (fr) Procede de detection d'une contamination fongique
EP2187217A4 (fr) Procede de detection de cancer gynecologique
EP2524056A4 (fr) Amplification multiplex pour la détection de variations d'acide nucléique
EP2111248A4 (fr) Système de détection
EP2235806A4 (fr) Systeme et procede de detection et d'interruption de defaut de terre
EP2024509A4 (fr) Procédé de détection
EP2207037A4 (fr) Procédé de détection d'un cancer
FR2953940B1 (fr) Procede de geo-referencement d'une zone imagee
EP2497073A4 (fr) Système acoustique passif de détection d'intrusion sous-marine
EP2494312A4 (fr) Procédé d'étalonnage de capteurs inertiels
EP2031051A4 (fr) Système de surveillance de culture
EP2227784A4 (fr) Système de détection de métastases du cancer des os
FR2897032B1 (fr) Systeme de detection d'occupant et procede de determination d'occupant
EP2147309A4 (fr) Procédés de détection de la prééclampsie
FR2906252B1 (fr) Procede de preparation d'halogenures de n-aklyl naltrexone
FR2901366B1 (fr) Procede de detection des reflecteurs d'une implusion electromagnetique
EP2176658A4 (fr) Procédés de détection de médicaments immunodépresseurs
EP2089873A4 (fr) Système de detection d'objets
EP2102370A4 (fr) Procede de surveillance d'une infection par le vih
FR2932885B1 (fr) Procede et dispositif de detection de la fluorescence d'une biopuce
BRPI0813681A2 (pt) Detecção de coproantígeno de nematelminto
FR2920024B1 (fr) Procede de purification ou de detection d'une proteine cible
FR2877862B1 (fr) Procede de detection des vibrations d'une cage de laminoir
FR2962222B1 (fr) Procede de detection d'interactions moleculaires

Legal Events

Date Code Title Description
CD Change of name or company name

Owner name: BIO RAD INNOVATIONS, FR

Effective date: 20111011

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

TP Transmission of property

Owner name: BIO-RAD EUROPE GMBH, CH

Effective date: 20200109

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18